These findings show how AI applications ... can support clinicians at one of the most consequential decision points in ...

Temporal trends and factors associated with overuse of neoadjuvant androgen deprivation therapy in low and very low risk prostate cancer. Changes in multiparametric prostate MRI and immune subsets in ...

Patterns of failure after radiotherapy (RT) in patients with prostate cancer re-staged with 18F-DCFPyL PSMA-PET: A regional cohort analysis.

The goal of this investigation was to retrospectively compare the recently proposed Prostate Imaging Reporting and Data System (PI-RADS) scale with the older Likert scale, using multiparametric MRI in ...

According to a study published in the American Journal of Roentgenology (AJR), upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between ...

A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...

Using a targeted biopsy-only approach for PI-RADS 3 lesions misses clinical significant prostate cancers in a large subset of men. Omitting systematic biopsy after multiparametric magnetic resonance ...